Detalles de la búsqueda
1.
Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG.
Blood
; 142(23): 1960-1971, 2023 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37647654
2.
Occupational exposure to extremely low-frequency magnetic fields and follicular lymphoma risk: a family case-control study.
Occup Environ Med
; 80(10): 599-602, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722828
3.
Challenges associated with test dose pharmacokinetic predictions of high dose melphalan exposure in patients with multiple myeloma.
Eur J Clin Pharmacol
; 78(12): 1911-1921, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205743
4.
Australia and New Zealand Transplant and Cellular Therapies COVID-19 vaccination consensus position statement.
Intern Med J
; 51(8): 1321-1323, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423546
5.
A multi-center randomized controlled trial to reduce unmet needs, depression, and anxiety among hematological cancer patients and their support persons.
J Psychosoc Oncol
; 38(3): 272-292, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31833452
6.
High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.
Br J Clin Pharmacol
; 82(1): 149-59, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26879446
7.
All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).
Blood
; 120(8): 1570-80; quiz 1752, 2012 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22715121
8.
A Population-Based Family Case-Control Study of Sun Exposure and Follicular Lymphoma Risk.
Cancer Epidemiol Biomarkers Prev
; 33(1): 106-116, 2024 01 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37831120
9.
How comparable are patient outcomes in the "real-world" with populations studied in pivotal AML trials?
Blood Cancer J
; 14(1): 54, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38531863
10.
Lymphoma cell-of-origin assignment by gene expression profiling is clinically meaningful across broad laboratory contexts.
Br J Haematol
; 181(2): 272-275, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28198001
11.
Raccoon eyes in systemic light chain amyloidosis.
Med J Aust
; 206(9): 384, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28490298
12.
Associations between Smoking and Alcohol and Follicular Lymphoma Incidence and Survival: A Family-Based Case-Control Study in Australia.
Cancers (Basel)
; 14(11)2022 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35681690
13.
Associations between early-life growth pattern and body size and follicular lymphoma risk and survival: a family-based case-control study.
Cancer Epidemiol
; 80: 102241, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36058036
14.
Dietary intake of animal-based products and likelihood of follicular lymphoma and survival: A population-based family case-control study.
Front Nutr
; 9: 1048301, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36687712
15.
Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy.
Br J Clin Pharmacol
; 69(5): 484-97, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20573084
16.
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis.
Br J Haematol
; 157(6): 766-9, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22390735
17.
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
J Clin Oncol
; 35(15): 1678-1685, 2017 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28368672
18.
Are Australian clinicians monitoring medication adherence in hematological cancer survivors? Two cross-sectional studies.
Exp Hematol Oncol
; 4: 15, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26082857
19.
Use of arsenic trioxide in remission induction and consolidation therapy for acute promyelocytic leukaemia in the Australasian Leukaemia and Lymphoma Group (ALLG) APML4 study: a non-randomised phase 2 trial.
Lancet Haematol
; 2(9): e357-66, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26685769
20.
The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complications.
Pathology
; 50(7): 775-776, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262184